+499.5%
MRNA vs GME
-15.8%
+515.3%
-34.2%
Performance
Returns, benchmark comparison, and relative performance.
Performance by timeframe
Returns for 1y.
| Period | Portfolio | GME | Excess | Alpha |
|---|---|---|---|---|
| 1D | -2.2% | -0.4% | -1.9% | -2.1% |
| 7D | +5.5% | +7.2% | -1.7% | +2.4% |
| 30D | +158.7% | +0.8% | +157.9% | +157.0% |
| 3M | +182.1% | -14.0% | +196.1% | +195.9% |
| 6M | +151.8% | -19.7% | +171.5% | +165.5% |
| YTD | +393.6% | -4.6% | +398.1% | +388.5% |
| 1Y | +499.5% | -14.3% | +513.8% | +477.0% |
| All | +499.5% | -15.8% | +515.3% | +477.0% |
Cumulative growth
Daily Returns
Daily percentage return beside GME.
Daily Out/Under-Performance
Portfolio return minus GME return. Positive bars indicate outperformance.
Daily Alpha
Portfolio daily return minus β × GME return. Early observations use the first valid beta; later observations use the trailing beta estimated for each date.
Cumulative Out/Under-Performance
Relative wealth over 1y: compounded portfolio wealth divided by compounded GME wealth, less one. Both series rebase at the selected span's start.
Cumulative Alpha
Compounded beta-adjusted residual returns apply the first valid beta to early observations, then the trailing beta ending on each date.
Updating return analytics…
1y analysis · Full analysis span regression · 6 months rolling